tiprankstipranks
Trending News
More News >
MedAvail Holdings (MDVLQ)
OTHER OTC:MDVLQ
US Market

MedAvail Holdings (MDVLQ) Ratios

Compare
159 Followers

MedAvail Holdings Ratios

MDVLQ's free cash flow for Q2 2023 was $0.44. For the 2023 fiscal year, MDVLQ's free cash flow was decreased by $ and operating cash flow was $-13.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio
4.03 3.65 8.39 1.84-
Quick Ratio
2.86 3.13 8.02 1.24-
Cash Ratio
1.93 2.62 7.61 1.15-
Solvency Ratio
-3.87 -2.16 -3.03 -0.17-
Operating Cash Flow Ratio
-8.02 -5.67 -3.76 -2.55-
Short-Term Operating Cash Flow Coverage
-67.32 0.00 -13.25 0.00-
Net Current Asset Value
$ 11.62M$ 8.31M$ 55.60M$ -100.56M-
Leverage Ratios
Debt-to-Assets Ratio
0.21 0.32 0.05 0.75-
Debt-to-Equity Ratio
0.34 0.64 0.06 -0.14-
Debt-to-Capital Ratio
0.25 0.39 0.05 -0.16-
Long-Term Debt-to-Capital Ratio
0.23 0.33 0.00 -0.15-
Financial Leverage Ratio
1.59 2.00 1.14 -0.19-
Debt Service Coverage Ratio
-22.19 -69.01 -7.26 -27.10-
Interest Coverage Ratio
-39.61 -73.87 -20.55 -28.40-
Debt to Market Cap
2.44 0.21 0.03 0.03-
Interest Debt Per Share
6.27 19.65 41.23 22.58-
Net Debt to EBITDA
0.10 0.18 2.29 -0.25-
Profitability Margins
Gross Profit Margin
6.00%1.43%36.96%25.14%-
EBIT Margin
-107.68%-195.33%-183.05%-551.55%-
EBITDA Margin
-96.73%-183.68%-170.13%-508.01%-
Operating Profit Margin
-107.69%-196.62%-182.57%-552.74%-
Pretax Profit Margin
-110.40%-197.99%-191.94%-571.02%-
Net Profit Margin
-110.45%-198.00%-191.94%-571.02%-
Continuous Operations Profit Margin
-110.45%-198.00%-191.94%-571.02%-
Net Income Per EBT
100.05%100.00%100.00%100.00%-
EBT Per EBIT
102.52%100.70%105.13%103.31%-
Return on Assets (ROA)
-143.72%-114.87%-38.67%-119.61%-
Return on Equity (ROE)
-238.69%-229.72%-43.90%22.28%-
Return on Capital Employed (ROCE)
-170.73%-142.01%-41.32%-201.82%-
Return on Invested Capital (ROIC)
-166.48%-138.92%-40.91%-198.59%-
Return on Tangible Assets
-145.76%-122.24%-38.80%-120.07%-
Earnings Yield
-2010.85%-95.84%-31.13%-5.97%-
Efficiency Ratios
Receivables Turnover
19.52 18.61 9.19 9.06-
Payables Turnover
24.19 8.81 6.58 6.90-
Inventory Turnover
5.84 5.57 3.13 0.61-
Fixed Asset Turnover
5.05 2.69 2.77 1.00-
Asset Turnover
1.30 0.58 0.20 0.21-
Working Capital Turnover Ratio
2.28 0.58 0.45 0.98-
Cash Conversion Cycle
66.10 43.69 100.99 581.37-
Days of Sales Outstanding
18.70 19.61 39.72 40.27-
Days of Inventory Outstanding
62.48 65.53 116.78 593.98-
Days of Payables Outstanding
15.09 41.45 55.51 52.88-
Operating Cycle
81.19 85.14 156.49 634.25-
Cash Flow Ratios
Operating Cash Flow Per Share
-36.23 -65.10 -250.21 -30.86-
Free Cash Flow Per Share
-37.98 -70.14 -257.35 -31.49-
CapEx Per Share
1.75 5.04 7.14 0.63-
Free Cash Flow to Operating Cash Flow
1.05 1.08 1.03 1.02-
Dividend Paid and CapEx Coverage Ratio
-20.69 -12.93 -35.05 -48.62-
Capital Expenditure Coverage Ratio
-20.69 -12.93 -35.05 -48.62-
Operating Cash Flow Coverage Ratio
-6.74 -3.47 -8.24 -1.44-
Operating Cash Flow to Sales Ratio
-1.11 -1.92 -2.05 -5.18-
Free Cash Flow Yield
-1720.05%-100.20%-34.20%-5.54%-
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.05 -1.04 -3.21 -16.74-
Price-to-Sales (P/S) Ratio
0.07 2.07 6.17 95.57-
Price-to-Book (P/B) Ratio
0.11 2.40 1.41 -3.73-
Price-to-Free Cash Flow (P/FCF) Ratio
-0.06 -1.00 -2.92 -18.07-
Price-to-Operating Cash Flow Ratio
-0.05 -1.08 -3.01 -18.44-
Price-to-Earnings Growth (PEG) Ratio
>-0.01 0.01 >-0.01 0.19-
Price-to-Fair Value
0.11 2.40 1.41 -3.73-
Enterprise Value Multiple
0.04 -0.94 -1.33 -19.06-
Enterprise Value
-1.46M 38.28M 31.66M 365.17M-
EV to EBITDA
0.04 -0.94 -1.33 -19.06-
EV to Sales
-0.03 1.73 2.27 96.84-
EV to Free Cash Flow
0.03 -0.84 -1.07 -18.31-
EV to Operating Cash Flow
0.03 -0.90 -1.11 -18.68-
Tangible Book Value Per Share
15.48 25.68 531.63 -152.59-
Shareholders’ Equity Per Share
15.83 29.20 533.62 -152.59-
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 -0.04 -0.03-
Revenue Per Share
32.77 33.88 122.06 5.95-
Net Income Per Share
-36.20 -67.09 -234.27 -34.00-
Tax Burden
1.00 1.00 1.00 1.00-
Interest Burden
1.03 1.01 1.05 1.04-
Research & Development to Revenue
0.03 0.04 0.05 0.29-
SG&A to Revenue
0.55 1.75 1.66 4.12-
Stock-Based Compensation to Revenue
0.05 0.05 0.03 0.09-
Income Quality
1.00 0.97 1.07 0.91-
Currency in USD